Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-04
DOI
10.3389/fnins.2019.01026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How far away from having an effective treatment option for progressive multiple sclerosis are we?
- (2017) Arianna Sartori et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy
- (2017) Serena Bonin et al. IMMUNOLOGICAL INVESTIGATIONS
- Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease
- (2016) Xiao-Yan Qin et al. JAMA Neurology
- Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
- (2016) Raed Alroughani et al. PLoS One
- Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
- (2015) Brit Fitzner et al. AUTOIMMUNITY REVIEWS
- Advances in the immunopathogenesis of multiple sclerosis
- (2015) Sudhir K. Yadav et al. CURRENT OPINION IN NEUROLOGY
- TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls
- (2015) Mehrdad Farrokhi et al. IMMUNOLOGICAL INVESTIGATIONS
- The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels
- (2015) Zohreh Babaloo et al. IMMUNOLOGY LETTERS
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- Perspectives on cytokine-directed therapies in multiple sclerosis
- (2015) B Schreiner et al. SWISS MEDICAL WEEKLY
- IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments
- (2014) Dirk W. Luchtman et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Th17 cells in central nervous system autoimmunity
- (2014) Christopher Sie et al. EXPERIMENTAL NEUROLOGY
- Microbial view of central nervous system autoimmunity
- (2014) Kerstin Berer et al. FEBS LETTERS
- Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS
- (2014) A. K. Huber et al. NEUROLOGY
- Pharmacogenomics of interferon beta and glatiramer acetate response: A review of the literature
- (2013) Sunil Mahurkar et al. AUTOIMMUNITY REVIEWS
- Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome
- (2013) Rotem Orbach et al. Multiple Sclerosis Journal
- CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions
- (2013) Enrique Alvarez et al. Multiple Sclerosis Journal
- The utility of cerebrospinal fluid analysis in patients with multiple sclerosis
- (2013) Martin Stangel et al. Nature Reviews Neurology
- Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies
- (2012) Amedeo Amedei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation
- (2012) Bibiana Bielekova et al. PLoS One
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
- (2011) S. Simpson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid
- (2011) Samia Ragheb et al. Multiple Sclerosis Journal
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- Multiple sclerosis: Geoepidemiology, genetics and the environment
- (2009) Ron Milo et al. AUTOIMMUNITY REVIEWS
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started